Navigation Links
Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record
Date:11/2/2009

MAARSSEN, The Netherlands, Nov. 2 /PRNewswire/ -- Returning confidence across the global pharma ingredients and services sector was marked by the buoyant CPhI Worldwide and co-located exhibitions -- ICSE, P-MEC and BioPh -- in sunny Madrid last month (12 - 15 October). Provisional figures from organisers UBM International Media showed a 5% increase in visitors over the record 2008 events in Frankfurt. Subject to audit, total attendance was over 25,450 - only 300 below last year.

Exhibitor numbers at the co-located CPhI ingredients, ICSE contract services, P-MEC equipment and BioPh biopharma exhibitions - together the world's largest pharma services event -- were up by over 100 to a record total of 1,808.

Combined first time exhibitor bookings also increased, with 114 companies making their debut in Madrid -- a 20% increase over 2008.

"Our provisional figures show the steady return of confidence in the pharma services sector," commented CPhI Event Director Annemieke Timmers. "Given the financial climate in early 2009, exhibitors assigned fewer staff to this year's events, but an impressive rise in visitor numbers delivered a total attendance within 1% of the 2008 record."

On event feedback, Ms. Timmers added: "Exhibitors were positive about enquiry volumes and quality. Expected to be cautious, the underlying business mood was upbeat. This year's rise in both overall and first-time exhibitor numbers is further confirmation of the business value generated by CPhI and its co-located events."

Haf Cennydd, Event Director for ICSE, P-MEC and BioPh, noted: "Footfall in ICSE and P-MEC reflected strong year-on-year gains in pre-registrations, together with high levels of interest for the 2010 events."

New features at this year's twentieth staging of CPhI Worldwide included the debut of the biotech-focused
'/>"/>

SOURCE CPhI Worldwide
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
2. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
5. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
6. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
7. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Hearing health affects a man,s lifestyle, ... remain socially and professionally engaged, he should address any hearing ... that the Better Hearing Institute (BHI) is delivering ... Men,s Health Week , which leads up to and includes ... June 10 through June 16. To help ...
(Date:5/23/2013)... More than half of women diagnosed with ... and still have excellent outcomes. To educate women, Agendia, ... largest sources of online consumer information about breast cancer ... provide recently diagnosed women with information sources, to help ... "We anticipate these innovative social media campaigns will ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... an emphasis on serving the healthcare needs of ... study in a U.S. clinical practice comparing breast ... tomosynthesis) with conventional 2D mammography alone showed a ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... Society of Pain Management Providers ( www.flspmp.org ), The ... The American Academy of Pain Management ( www.aapainmanage.org ) ... Bondi for their support of the Prescription Drug Monitoring ... attempt to repeal the program. These three ...
... CITY, Feb. 15, 2011 Dynatronics Corporation (Nasdaq: ... approved a $1 million open market share repurchase program of ... the confidence of management and our board of directors in ... shareholder value," said Kelvyn H. Cullimore, president of Dynatronics. "Based ...
Cached Medicine Technology:Florida Pain Clinic Organizations Applaud FL Senate President Haridopolos and Attorney General Bondi 2Dynatronics Announces $1 Million Stock Buyback Program 2
(Date:5/23/2013)... A modified version of the polio virus might ... suggests. Scientists at Duke Cancer Institute said ... an engineered form of the virus that is ... The therapy shows promise in the treatment of ... they said. "These early results are intriguing," ...
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 “Talk. ... (PSA) campaign that empowers parents to talk to children ... of underage drinking, was launched today by the Substance ... The kickoff occurred in conjunction with SAMHSA’s 2013 National ... of, and action around, substance abuse and mental health ...
(Date:5/23/2013)... researchers have used next generation genomic analysis to determine ... have similar genetic origins, which may help in predicting ... journal Cancer Research . , "This is the ... sequencing in adjacent Gleason patterns in the same tumor ... says ,John Cheville, M.D., Mayo Clinic pathologist and one ...
(Date:5/23/2013)... Former United States Vice President Dick Cheney served ... Paramedic Luncheon. , In front of 1,500 guests ... medics, saying, "I am delighted to be here to ... of the Year Award. I think it's a tremendous ... within a company like this because there are obviously ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Jeanne Ettelson, ... anniversary of its popular and only free OCD support ... successful continuing resource for OCD sufferers, the group is ... and related disorders. This allows group participants to ... Exposure and Response Prevention. , “Participants in Beyond OCD’s ...
Breaking Medicine News(10 mins):Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Beyond OCD Support Group Marks Fifth Anniversary 2
... of MRI before surgeries, researchers report , , FRIDAY, ... rates, the number of mastectomies performed on women with ... Clinic now reports. , The increase coincided ... surgery, according to the authors, who were expected to ...
... 16 Tempo Participacoes,S.A. (Bovespa: TEMP3; Reuters: ... healthcare administration services, dental benefit plans and,specialized ... the first,quarter of 2008. The operating and ... is presented in Brazilian Reais and in,accordance ...
... INDIANAPOLIS, May 15 Lung cancer patients,whose histology is ... according to data from a pivotal non-small cell lung ... Eli Lilly and Company,s,ALIMTA(R) (pemetrexed for injection), will be ... of Clinical Oncology (ASCO) in Chicago,Ill., May 30 -- ...
... of a protein called IGF-1R in patients with gastrointestinal ... be less responsive to the drug imatinib mesylate (known ... researcher at the Fox Chase Cancer Center in Philadelphia. ... Gleevec-resistant cells, might respond well to agents in development ...
... JumpStart Inc., the Northeast Ohio,venture development organization ... and ideas, has announced an investment commitment ... is,commercializing a patented, Federal Drug Administration cleared ... cervical length in,pregnant women, which has been ...
... BARBARA, Calif., May 15 Congresswoman Lois Capps,(D-CA) and ... organized a,briefing for key staff members of the House, ... WHEN: Monday, May 19th at 2 PM, ... of discussants includes Mary Hesdorffer, a nurse practitioner and,the ...
Cached Medicine News:Health News:Mastectomies on the Increase 2Health News:Mastectomies on the Increase 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Protein predicts Gleevec resistance in gastrointestinal tumors 2Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
... This conservative, resurfacing implant is an ... a bone sparing option. The implant is ... undersurface Porocoat porous coating or DuoFix HA ... patients with degenerative arthritis, rheumatoid or moderately ...
... a laser-cut stent, is the latest in ... for use after coronary arteries have been ... known as percutaneous transluminal coronary angioplasty (PTCA). ... of features designed to optimize scaffolding, radiopacity ...
... stent technology with no compromises. It's the ... results. With S670's discrete, low-profile delivery system, ... excellent clinical results you want. S670, the ... compromises. It's the stent that delivers like ...
Medicine Products: